Part of this company's portfolio (“Nutritional Supplement / Multivitamin”) is registered under a
broad DRAP category rather than distinct molecules, so the molecule count
understates its true range.
Company overview
102
registered products
75
pharmaceutical brands
78
distinct molecules
11
therapeutic classes
10
DRAP alerts
Otsuka Pakistan Limited is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 102 product registrations across 78 distinct molecules. It is the 175th largest registrant in Pakistan by product count, and ranks 1st of 11 in Solutions Affecting The Electrolyte Balance. Its portfolio is concentrated in Solutions Affecting The Electrolyte Balance and Amino Acid Solution. DRAP has issued 11 alerts involving its products.
Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.
Products by Otsuka
51 products matched in our catalogue — each with its observed price and DRAP approved ceiling.
DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.
This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.